NCT06940999

Brief Summary

This study uses a mixed-method design combining a quasi-experimental, single-group pre-post intervention with a methodological validation approach.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2025

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2025

Completed
Last Updated

April 23, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

April 16, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

Image-based assessmentScar extensibility assessment.

Outcome Measures

Primary Outcomes (3)

  • Vancouver Scar Scale (VSS)

    to evaluate vascularity, pigmentation, pliability, and scar height.

    Baseline and three months after the intervention

  • Firmness and pliability at the scar site

    Tonometry will be used to assess tissue firmness and pliability at the scar site.

    Baseline and three months after the intervention

  • Proposed Image-Based Method

    the scar images before and after the intervention will go through three steps: * Image Acquisition: High-resolution digital images of scars will be captured using a standardized protocol (fixed camera settings, lighting, distance). * Image Preprocessing: Images will be converted to grayscale, and regions of interest (ROI) manually or automatically defined. * Image Analysis: The standard deviation (STD) of pixel intensities within the ROI will be calculated as an indicator of tissue extensibility and collagen fiber cross-linking patterns will be detected and quantified using advanced image processing algorithms.

    Baseline and three months after the intervention

Study Arms (1)

Traditional physical therapy group

EXPERIMENTAL

This study uses a mixed-method design combining a quasi-experimental, single-group pre-post intervention with a methodological validation approach. Participants will receive a standardized physical therapy protocol targeting scar contracture. After intervention, scar extensibility will be measured using traditional tools (Vancouver Scar Scale, tonometer) and a newly developed image-based method. The image-based method will be tested for: * Reliability (test-retest, inter-rater) * Validity (concurrent validity against established tools and construct validity)

Other: Traditional physical therapy

Interventions

Application of laser three times per week in addition to applying deep friction massage, stretching exercises along with the uses of pressure garment.

Traditional physical therapy group

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • History of clinically diagnosed scar contracture following thermal burns.
  • Presence of scars (≥6 months post-burn) to ensure stability for accurate assessment.
  • Scars located on functionally mobile areas (e.g., limbs) where extensibility impacts daily activities.
  • Willingness to undergo a standardized physical therapy intervention.
  • Ability to provide informed consent and comply with all study procedures.

You may not qualify if:

  • Active infection, unhealed wounds, or unstable scars at the assessment site.
  • Diagnosed systemic diseases affecting collagen synthesis or wound healing (e.g., scleroderma, uncontrolled diabetes).
  • History of experimental or non-standard scar treatment within the last 3 months.
  • Severe cognitive impairments or communication barriers that interfere with understanding or participation.
  • Pregnant or lactating women, due to hormonal influences on tissue healing and collagen metabolism.
  • Concurrent participation in other physical therapy or rehabilitation studies targeting scar management.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaimaa Mohamed Ahmed Elsayeh

Cairo, New Cairo, 02, Egypt

Location

MeSH Terms

Conditions

Cicatrix, Hypertrophic

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Shaimaa MA Elsayeh, PhD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Mixed-method design combining quasi-experimental and instrument validation approaches
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof. Dr.

Study Record Dates

First Submitted

April 16, 2025

First Posted

April 23, 2025

Study Start

August 15, 2024

Primary Completion

May 4, 2025

Study Completion

May 12, 2025

Last Updated

April 23, 2025

Record last verified: 2025-04

Locations